Skip to Content

M 27 (Methylphenidate hydrochloride extended-release 27 mg)

Pill imprint M 27 has been identified as Methylphenidate hydrochloride extended-release 27 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; obesity; depression; severe mood dysregulation (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 27 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Methylphenidate hydrochloride extended-release 27 mg M 27
Methylphenidate hydrochloride extended-release
Imprint:
M 27
Strength:
27 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Mallinckrodt, Inc.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide